Detalhe da pesquisa
1.
BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases.
Haematologica
; 109(2): 493-508, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560801
2.
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies.
Int J Hematol
; 117(3): 388-397, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449134